High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Men Who Have Sex With Men-Reference-Cited by-同舟云学术

High Cure Rates With Grazoprevir-Elbasvir With or Without Ribavirin Guided by Genotypic Resistance Testing Among Human Immunodeficiency Virus/Hepatitis C Virus–coinfected Men Who Have Sex With Men

Published:2018-08-13 Issue:4 Volume:68 Page:569-576
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Braun Dominique L¹²,Hampel Benjamin¹²,Kouyos Roger¹²,Nguyen Huyen¹,Shah Cyril²,Flepp Markus³,Stöckle Marcel⁴,Conen Anna⁵,Béguelin Charles⁶,Künzler-Heule Patrizia⁷,Nicca Dunja⁷,Schmid Patrick⁸,Delaloye Julie⁹,Rougemont Mathieu¹⁰,Bernasconi Enos¹¹,Rauch Andri⁶,Günthard Huldrych F¹²,Böni Jürg²,Fehr Jan S¹¹²,Anagnostopoulos A,Battegay M,B E,B J,B D L,Bucher H C,Calmy A,Cavassini M,Ciuffi A,Dollenmaier G,Egger M,Elzi L,F J S,Fellay J,Furrer H,Fux C A,G H F,Haerry D,Hasse B,Hirsch H H,Hoffmann M,Hösli I,Huber M,Kahlert C,Kaiser L,Keiser O,Klimkait T,K R,Kovari H,Ledergerber B,Martinetti G,Martinez de Tejada B,Marzolini C,Metzner K J,Müller N,N D,Paioni P,Pantaleo G,Perreau M,R A,Rudin C,Scherrer A U,S P,Speck R,S M,Tarr P,Trkola A,Vernazza P,Wandeler G,Weber R,Yerly S,

Affiliation:

1. Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, University of Zurich, Switzerland

2. Institute of Medical Virology, University of Zurich

3. Center of Infectious Diseases Zurich

4. Division of Infectious Diseases & Hospital Epidemiology, University Hospital Basel, University of Basel

5. Division of Infectious Diseases and Hospital Hygiene, Cantonal Hospital Aarau

6. Department of Infectious Diseases, Bern University Hospital, University of Bern

7. Institute of Nursing Science, University Hospital Basel, University of Basel

8. Division of Infectious Diseases, Cantonal Hospital St Gallen

9. Intensive Care Unit, Department of Intensive Care Medicine, University of Lausanne and University Hospital Center

10. Division of Infectious Diseases, University Hospital Geneva

11. Division of Infectious Diseases, Regional Hospital Lugano

12. Department Public Health, Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Switzerland

Funder

Merck Sharp and Dohme

Swiss National Science Foundation

SHCS research foundation

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/68/4/569/27662753/ciy547.pdf

Reference31 articles.

1. Increasing burden of liver disease in patients with HIV infection;Joshi;Lancet,2011

2. Viral hepatitis in HIV infection;Koziel;N Engl J Med,2007

4. Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-Infected persons in the Swiss HIV Cohort Study;Kovari;Clin Infect Dis,2017

5. Incidence of hepatitis C in HIV positive and negative men who have sex with men 2000-2016: a systematic review and meta-analysis;Ghisla;Infection,2017

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring group differences in the response to a sexual risk reduction intervention to prevent hepatitis C virus reinfection in HIV-infected MSM: a mixed-methods study;AIDS Care;2023-05-14

2. Evaluating interventions to reduce behaviour associated with HCV reinfection in men who have sex with men: study protocol for a non-blinded, phase 2, randomised trial;Trials;2023-03-15

3. Evaluating interventions to reduce behaviour associated with HCV reinfection in men who have sex with men: study protocol for a non-blinded, phase 2, randomised trial;2023-01-27

4. Low Spontaneous Clearance Rates of Recently Acquired Hepatitis C Virus in Human Immunodeficiency Virus–Positive Men Who Have Sex With Men (PROBE-C Study);Clinical Infectious Diseases;2022-08-25

5. Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression;The Lancet HIV;2022-06